[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594639":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":35,"responsibleParty":51,"collaborators":54,"id":59,"slug":18,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":18,"enrollmentInfo":67,"targetDuration":18,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":18,"overallStatus":38,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Telemonitoring","EXPERIMENTAL","The patient in the experimental arm downloads a telemonitoring application where they enter their pressure and body weight data, which is revised by the hospital team via a platform. The patient complete a questionnaire during enrollment and during two follow-ups (3 months and 6 months) to examine various dimensions.",[13],"Device: Telemonitoring app",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard care","NO_INTERVENTION","The patient in the standard care arm do not downloads a telemonitoring application, but they continue with normal medical indication. The patient complete a questionnaire during enrollment and during two follow-ups (3 months and 6 months) to examine various dimensions.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","Telemonitoring app","periodic measurement of blood pressure and body weight",[9],[26],{"name":27,"affiliation":28,"role":29},"Stefano Prof. Carugo","IRCCS Fondazione Caì Granda Ospedale Maggiore Policlinico","PRINCIPAL_INVESTIGATOR",[31],{"name":27,"role":32,"phone":33,"phoneExt":18,"email":34},"CONTACT","+390255033532","stefano.carugo@policlinico.mi.it",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":40,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","RECRUITING","Milan","Italy","20122",{"type":43,"coordinates":44},"Point",[45,46],9.18951,45.46427,{"lat":46,"lon":45},[49],{"name":50,"role":32,"phone":33,"phoneExt":18,"email":34},"Prof. Carugo",{"type":29,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Stefano Carugo","Director of the Department of Cardio-Thoracic-Vascular Diseases",[55,57],{"name":56,"class":6},"ASST Grande Ospedale Metropolitano Niguarda",{"name":58,"class":6},"University of Milan","100594639",false,"NCT07022067","EVOLVING AZIMUTH IN MUSA CONTEXT","AZIMUSA","Inclusion Criteria:\n\n* Have been diagnosed with chronic CS according to the ESC guidelines;\n* Over 18 years of age;\n* Patients admitted to hospital or with access to first aid within the last year;\n* Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);\n* Wi-Fi or 3G coverage at home;\n* Ability to give written informed consent.\n\nExclusion Criteria:\n\n* Severe psychiatric disorder\n* Inability to use portable technologies\n* Patients unable to use the equipment provided\n* Patients who deny consent to study participation","ALL","18 Years",{"count":68,"type":69},184,"ESTIMATED","INTERVENTIONAL",[72],"NA","Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure",[75,76,77,9],"Heart Failure","Blood Pressure","Weight Change","2025-06-11",{"date":80,"type":81},"2025-06-15","ACTUAL",{"date":83,"type":81},"2024-10-02",{"date":85,"type":69},"2025-08-31",{"name":5,"class":6},1]